Systemic lupus erythematosus during pregnancy is not associated with school performance in offspring - A Danish

Signe S Knudsen1,2,3, Julia F Simard2, Jakob S Knudsen4

  • 1Department of Public Health, Aarhus University, Aarhus, Denmark.

Lupus
|November 16, 2020
PubMed

Insights

Children born to mothers with Systemic Lupus Erythematosus (SLE) show no difference in school test performance. In utero exposure to SLE, hydroxychloroquine, or immunosuppressants did not harm neurocognitive development.

Area of Science:

  • Obstetrics and Gynecology
  • Pediatrics
  • Rheumatology

Background:

  • Systemic Lupus Erythematosus (SLE) in pregnancy is linked to adverse offspring outcomes, including neurodevelopmental disorders.
  • Long-term cognitive development in children of mothers with SLE is not well-studied.

Purpose of the Study:

  • To compare the long-term cognitive development of children born to mothers with SLE versus the general population.
  • To investigate the impact of in utero exposure to SLE and related medications on child neurocognition.

Main Methods:

  • Utilized Danish National School Test data (grades 2-8) for reading and mathematics.
  • Included 738,862 children born in Denmark (1995-2008), identifying 312 born to mothers with SLE.
  • Analyzed medication exposures (hydroxychloroquine, immunosuppressants) during pregnancy.

Main Results:

  • No significant differences in reading or mathematics test scores were found between children of mothers with and without SLE.
  • A non-significant trend towards lower scores was observed in children exposed to hydroxychloroquine/immunosuppressants, but not in those exposed for non-SLE reasons.

Conclusions:

  • In utero exposure to SLE, hydroxychloroquine, and/or immunosuppressants does not appear to cause major harm to neurocognitive development as measured by school performance.
  • This study suggests a favorable long-term cognitive outlook for children born to mothers with SLE.
Abstract

Related Concept Videos